Ignite Creation Date:
2024-05-06 @ 7:50 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06158958
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2023-11-29
Brief Title:
A Study to Assess the Safety Pharmacokinetics and Efficacy of Intravenous IV ABBV-303 as Monotherapy and in Combination With IV Infused Budigalimab ABBV-181 in Adults With Advanced Solid Tumors
Sponsor:
AbbVie
Organization:
AbbVie
Organization Data
Organization:
AbbVie
Class:
INDUSTRY
Study ID:
M24-122
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AbbVie
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None